EUVIMED · CrossrefJournal
npj Breast Cancer
ISSN 2374-4677 · Springer Science and Business Media LLC
Latest articles
Real-world rates and sites of recurrence after neoadjuvant chemoimmunotherapy in early-stage triple-negative breast cancer
Directional mitochondrial transfer and microenvironmental adaptation in breast cancer
Coordinated patterns of genomic instability and immunogenicity predict 10-year breast cancer progression across subtypes and patient characteristics
Nucleotide excision repair deficiency identified by mutational signatures is associated with cisplatin response in triple-negative breast cancer
Hypermethylation in CpG-rich cfDNA fragments enables accurate detection of circulating tumor DNA in BRCA1- and BRCA2-associated breast and ovarian cancer
First-line CDK4/6 inhibitors in HR+/HER2− metastatic breast cancer with chronic kidney disease stage 3b–5: a target trial emulation
Genomic characterization of ER-positive primary tumors and corresponding relapses identifies potentially targetable alterations
AI-derived tumor-infiltrating lymphocytes enhance the prediction of pathologic complete response in early-stage triple-negative breast cancer
Benchmarking of pathology foundation models for assessing HER2 amplification and CEP17 polysomy in breast cancer
Artificial intelligence-enabled analysis of electron micrographs to assess mitochondrial morphology in triple-negative breast cancer
Hepatic stellate cell activation in the postpartum liver is consistent with pre-metastatic niche establishment
Single-cell decoding of breast cancer organotropism: ecosystem mapping for precision therapy
Role of tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer treated with KEYNOTE-522 in real-world setting
Beyond a single disease: review of rare histological subtypes of triple-negative breast cancer with implications for prognosis and treatment
QuTILs: open-source image-based infiltrating immune cell detection for research application
Differential response and survival across rare histologic subtypes of triple-negative breast cancer following neoadjuvant chemo-immunotherapy
Quantitative and qualitative patient-reported analysis of misdiagnosis and/or late diagnosis of metastatic lobular cancer
Prospective assessment of a quantitative immunofluorescent assay to measure HER2 and TROP2 concentrations on a single tissue biopsy slide
Spatial organization of the tumor-immune microenvironment in ER-positive breast cancer with treatment remodeling and associated clinical responses
“Molecular divergence shapes lung- and liver-preferential metastasis in HER2-positive breast cancer”
Multi-analyte liquid biopsy characterization of metastatic inflammatory breast cancer: comparison with non-inflammatory breast cancer
Preventive effect of compression on breast cancer–related lymphedema after docetaxel chemotherapy: a randomized controlled trial
Association of patient-reported stress and pain with survival in nonmetastatic breast cancer: secondary analysis of Alliance A011502
An Artificial Intelligence (AI) model integrating multiscale foundation model histopathology representations with molecular and clinical features predicts early and late distant recurrence in TAILORx
Immune landscape in PD-L1- and TROP2-positive triple-negative breast cancer
Ethnic differences in nonalcoholic fatty liver disease among women with early-stage breast cancer receiving endocrine therapy
Adaptive immune microenvironment associated with prolonged disease-free interval in estrogen receptor positive breast cancer
External validation of four breast cancer risk prediction models for personalized screening in a prospective Dutch screening cohort
Circulating tumor DNA as an arbitrator for postmastectomy radiotherapy: bridging molecular residual disease and locoregional control
Validation of pathology-based triage for the 21-gene recurrence score: a meta-analysis and qualitative synthesis of the Magee equations
EUVIMED